S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
NASDAQ:ATEC

Alphatec (ATEC) Stock Price, News & Analysis

$13.95
+0.15 (+1.09%)
(As of 10:57 AM ET)
Today's Range
$13.88
$14.18
50-Day Range
$12.80
$16.78
52-Week Range
$8.66
$19.14
Volume
325,612 shs
Average Volume
1.66 million shs
Market Capitalization
$1.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.50

Alphatec MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
69.4% Upside
$23.63 Price Target
Short Interest
Bearish
7.99% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
0.85mentions of Alphatec in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$3.53 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.10) to ($0.78) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.66 out of 5 stars

Medical Sector

77th out of 939 stocks

Surgical & Medical Instruments Industry

12th out of 98 stocks

ATEC stock logo

About Alphatec Stock (NASDAQ:ATEC)

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

ATEC Stock Price History

ATEC Stock News Headlines

Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Alphatec (NASDAQ:ATEC) Shares Gap Up Following Analyst Upgrade
Shhh! 7 Small-Cap Stocks That Can Double by 2025
A Closer Look at 4 Analyst Recommendations For Alphatec Holdings
Positive Outlook for Alphatec Holdings Justifies Buy Rating
See More Headlines
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ATEC
CUSIP
02081G10
Employees
839
Year Founded
1990

Price Target and Rating

Average Stock Price Target
$23.50
High Stock Price Target
$32.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+70.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-186,640,000.00
Pretax Margin
-38.76%

Debt

Sales & Book Value

Annual Sales
$482.26 million
Book Value
$0.57 per share

Miscellaneous

Free Float
97,800,000
Market Cap
$1.90 billion
Optionable
Optionable
Beta
1.58

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

ATEC Stock Analysis - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings
or view top-rated stocks.

What is Alphatec's stock price target for 2024?

7 brokers have issued 12-month price targets for Alphatec's stock. Their ATEC share price targets range from $17.00 to $32.00. On average, they anticipate the company's stock price to reach $23.63 in the next twelve months. This suggests a possible upside of 69.4% from the stock's current price.
View analysts price targets for ATEC
or view top-rated stocks among Wall Street analysts.

How have ATEC shares performed in 2024?

Alphatec's stock was trading at $15.11 at the beginning of 2024. Since then, ATEC stock has decreased by 7.7% and is now trading at $13.95.
View the best growth stocks for 2024 here
.

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ATEC earnings forecast
.

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) announced its quarterly earnings data on Tuesday, February, 27th. The medical technology company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.09. The medical technology company had revenue of $138 million for the quarter, compared to analyst estimates of $131.90 million. The firm's revenue for the quarter was up 30.3% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.33) EPS.

What ETFs hold Alphatec's stock?
What guidance has Alphatec issued on next quarter's earnings?

Alphatec issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $595.0 million-$595.0 million, compared to the consensus revenue estimate of $574.7 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?
Who are Alphatec's major shareholders?

Alphatec's stock is owned by a number of institutional and retail investors. Top institutional shareholders include First Light Asset Management LLC (4.39%), Vanguard Group Inc. (3.96%), Vanguard Group Inc. (3.91%), Point72 Asset Management L.P. (2.20%), Cerity Partners LLC (1.38%) and Royal Bank of Canada (1.18%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David M Demski, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal, Quentin S Blackford, Scott Lish and Tyson Eliot Marshall.
View institutional ownership trends
.

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATEC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners